Sichuan Jiuyiyuan Particle Technology

Sichuan Jiuyiyuan Particle Technology

Medical cyclotrons for radiopharmaceutical solutions.

HQ location
Sichuan, China
Launch date
Employees
Enterprise value
$206m
  • Edit
Notes (0)
More about Sichuan Jiuyiyuan Particle Technology
Made with AI
Edit

Sichuan Jiuyiyuan Particle Technology Co., Ltd., also known as Longevous Beamtech, is a high-tech enterprise established in February 2017 that specializes in the research, development, production, and servicing of high-end nuclear medical equipment. The company was incubated from the Institute of Fluid Physics at the China Academy of Engineering Physics (CAEP). This background provides a strong technical foundation, with the core team originating from the institute and leveraging years of research in cyclotron technology. The company operates under a mixed-ownership model, with state-owned capital participation, founding team shareholding, and private capital control.

The firm focuses on providing comprehensive solutions for radioactive drugs. Its primary products are medical cyclotrons, which are particle accelerators used to produce positron-emitting radioactive nuclides. These nuclides are essential for radiopharmaceuticals used in PET/CT and PET/MR scans for the early diagnosis of cancer, as well as for molecular imaging and precision therapy. The company has developed a range of cyclotrons, including the 7MeV, 11MeV, and 20MeV models, designed to serve various clients from small hospitals to large research institutions and pharmaceutical factories. The cyclotrons are capable of producing a variety of isotopes such as ¹⁸F, ¹¹C, ¹³N, and ⁶⁸Ga. Key features of their technology include a long-lifetime pluggable ion source, an advanced intelligent control system, and high-precision isochronous magnets.

Sichuan Jiuyiyuan Particle Technology has positioned itself as a key domestic player in a market historically dominated by foreign manufacturers, aiming to provide import substitutes. In 2021, the company's first domestically produced medical cyclotron was installed and began operation at Sichuan Science City Hospital, marking a significant milestone. The company has since expanded its operations, opening a new research, development, and production base in Mianyang in 2023. Its business model encompasses the entire product lifecycle, from R&D and manufacturing to solution design and after-sales support, serving a global client base.

Keywords: medical cyclotrons, radiopharmaceuticals, nuclear medicine equipment, particle accelerator, isotope production, positron emission tomography, cancer diagnosis, medical imaging, nuclear technology, healthcare technology, radiotherapy, PET drugs, cyclotron manufacturing, molecular imaging, precision medicine, high-tech enterprise, China Academy of Engineering Physics, medical equipment, oncology, diagnostic imaging

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads